Stereotaxis, Inc. (NASDAQ:STXS)

CAPS Rating: 3 out of 5

The Company designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite, or cath lab.

Featured Broker Partners


Advertisement